For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Nuvelo, Inc.

USPTO Granted Patents = 39

% Expired Patents = 76.9

Forward Citations = 469

Loading Chart...

Loading Chart...

69 inventors (with patents filed for the assignee):

Radoje Drmanac (13 out of 134 patents)

Y Tom Tang (13 out of 92 patents)

Brian Paul Chadwick (8 out of 9 patents)

4. Anna-Maria Frischauf (8 out of 9 patents)

5. George Yeung (7 out of 25 patents)

6. Chenghua Liu (7 out of 17 patents)

7. Bryan J Boyle (6 out of 10 patents)

8. Vincent P Stanton, Jr (5 out of 30 patents)

9. Nancy K Mize (5 out of 11 patents)

10. John E Ford (5 out of 18 patents)

11. Ryle W Goodrich (5 out of 5 patents)

12. Vinod Asundi (4 out of 5 patents)

13. Matthew C Arterburn (4 out of 6 patents)

14. Jian-Rui Wang (3 out of 4 patents)

15. Ivan Labat (3 out of 7 patents)

39 patents: Sort by Forward Citations

1. 8993726 - Antibodies to NTB-A (2015-03-31),

2. 7659054 - Methods for genetic analysis of DNA to detect sequence variances (2010-02-09),

3. 7439327 - Stem cell factor-like proteins and uses thereof (2008-10-21),

4. 7425610 - Methods and materials relating to CD84-like polypeptides and polynucleotides (2008-09-16),

5. 7411052 - Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides (2008-08-12),

6. 7320880 - Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same (2008-01-22),

7. 7319141 - Stem cell growth factor-like polypeptides (2008-01-15),

8. 7122373 - Human genes and gene expression products V (2006-10-17),

9. 7109030 - Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides (2006-09-19),

10. 7067301 - Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides (2006-06-27),

11. 7029677 - Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells (2006-04-18),

12. 7001731 - Chemokine receptor obtained from a cDNA library of fetal liver-spleen (2006-02-21),

13. 6979548 - Chemokine receptor obtained from a CDNA library of fetal liver-spleen (2005-12-27),

14. 6964868 - Human genes and gene expression products II (2005-11-15),

15. 6919193 - Nucleic acids and polypeptides (2005-07-19),

Nuvelo, Inc. is a biotechnology company specializing in the research and development of novel therapies for the treatment of cardiovascular and autoimmune diseases. With a focus on precision medicine and targeted therapies, Nuvelo aims to improve patient outcomes and quality of life. By leveraging advanced scientific techniques and technologies, the company is committed to discovering innovative solutions and advancing the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

39 Patents

#118 in Sunnyvale, CA

#2,085 in California

#8,804 in US

#17,399 in the World

Sunnyvale, CA, United States of America

Nuvelo, Inc.

Forward Citations = 469

69 inventors:

Radoje Drmanac (13 out of 134 patents)

Y Tom Tang (13 out of 92 patents)

Brian Paul Chadwick (8 out of 9 patents)

4. Anna-Maria Frischauf (8 out of 9 patents)

5. George Yeung (7 out of 25 patents)

Please report any incorrect information to [email protected]

Loading…